| Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy S Chatterjee, S Sinha, CN Kundu European Journal of Pharmacology 911, 174516, 2021 | 41 | 2021 |
| PARP inhibitor Veliparib (ABT-888) enhances the anti-angiogenic potentiality of Curcumin through deregulation of NECTIN-4 in oral cancer: Role of nitric oxide (NO) S Chatterjee, S Sinha, S Molla, KC Hembram, CN Kundu Cellular Signalling 80, 109902, 2021 | 38 | 2021 |
| Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19? S Sinha, CN Kundu Medical Oncology 38 (9), 101, 2021 | 37 | 2021 |
| Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway R Pradhan, S Paul, B Das, S Sinha, SR Dash, M Mandal, CN Kundu The Journal of Nutritional Biochemistry 113, 109257, 2023 | 21 | 2023 |
| PARP1-modulated chromatin remodeling is a new target for cancer treatment S Sinha, S Molla, CN Kundu Medical Oncology 38 (10), 118, 2021 | 21 | 2021 |
| Use of substitute Nonidet P-40 nonionic detergents in intracellular tubulin polymerization assays for screening of microtubule targeting agents S Sinha, JJ Field, JH Miller Biochemistry and Cell Biology 95 (3), 379-384, 2017 | 20 | 2017 |
| Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells B Das, SR Dash, H Patel, S Sinha, S Bhal, S Paul, C Das, R Pradhan, ... Phytomedicine 117, 154914, 2023 | 14 | 2023 |
| Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping S Chatterjee, AK Dhal, S Paul, S Sinha, B Das, SR Dash, CN Kundu Journal of Cancer Research and Clinical Oncology 148 (12), 3521-3535, 2022 | 14 | 2022 |
| NIR irradiation enhances the apoptotic potentiality of quinacrine-gold hybrid nanoparticles by modulation of HSP-70 in oral cancer stem cells SR Dash, S Chatterjee, S Sinha, B Das, S Paul, R Pradhan, C Sethy, ... Nanomedicine: Nanotechnology, Biology and Medicine 40, 102502, 2022 | 14 | 2022 |
| Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway S Sinha, S Chatterjee, S Paul, B Das, SR Dash, C Das, CN Kundu Experimental Cell Research 420 (1), 113338, 2022 | 13 | 2022 |
| Olaparib enhances curcumin-mediated apoptosis in oral cancer cells by inducing PARP trapping through modulation of BER and chromatin assembly S Molla, S Chatterjee, C Sethy, S Sinha, CN Kundu DNA repair 105, 103157, 2021 | 13 | 2021 |
| Microtubule-stabilizing properties of the avocado-derived toxins (+)-(R)-persin and (+)-(R)-tetrahydropersin in cancer cells and activity of related synthetic analogs JJ Field, A Kanakkanthara, DG Brooke, S Sinha, SD Pillai, WA Denny, ... Investigational new drugs 34, 277-289, 2016 | 12 | 2016 |
| Targeting cancer stem cells in the tumor microenvironment: An emerging role of PARP inhibitors S Paul, S Sinha, CN Kundu Pharmacological Research 184, 106425, 2022 | 11 | 2022 |
| Near-infrared enhances antiangiogenic potentiality of quinacrine-gold hybrid nanoparticles in breast cancer stem cells via deregulation of HSP-70/TGF-β SR Dash, B Das, C Das, S Sinha, S Paul, R Pradhan, CN Kundu Nanomedicine 18 (1), 19-33, 2023 | 9 | 2023 |
| Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells S Paul, S Chatterjee, S Sinha, SR Dash, R Pradhan, B Das, K Goutam, ... Expert Opinion on Therapeutic Targets 27 (10), 999-1015, 2023 | 6 | 2023 |
| Quinacrine inhibits cMET-mediated metastasis and angiogenesis in breast cancer stem cells B Das, C Sethy, S Chatterjee, SR Dash, S Sinha, S Paul, K Goutam, ... Journal of Cell Communication and Signaling 17 (4), 1371-1388, 2023 | 4 | 2023 |
| Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300 C Das, SR Dash, S Sinha, S Paul, B Das, S Bhal, C Sethy, CN Kundu Medical Oncology 40 (12), 351, 2023 | 4 | 2023 |
| Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through … R Pradhan, S Paul, SS Acharya, S Sinha, SR Dash, CN Kundu The Journal of Nutritional Biochemistry 125, 109568, 2024 | 3 | 2024 |
| Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60 … S Sinha, S Paul, SS Acharya, C Das, SR Dash, S Bhal, R Pradhan, B Das, ... Medical Oncology 41 (2), 49, 2024 | 2 | 2024 |
| Synthesis and Microtubule‐Destabilizing Activity of N‐Cyclopropyl‐4‐((3,4‐dihydroquinolin‐1(2H)‐yl)sulfonyl)benzamide and its Analogs JJ Field, AJ Singh, S Sinha, MR Rowe, WA Denny, DG Brooke, JH Miller Chemistry–An Asian Journal 14 (8), 1151-1157, 2019 | 1 | 2019 |
Chanakya Nath KunduProfessor, KIIT school of Biotechnology, KIIT University, Orissa, India在 kiitbiotech.ac.in 的电子邮件经过验证
